BioLineRx (BLRX) Projected to Post Quarterly Earnings on Monday

BioLineRx (NASDAQ: BLRX - Get Free Report) is expected to release its Q4 2025 results before the market opens on Monday, March 23rd. Analysts expect the company to announce earnings of ($0.50) per share and revenue of $0.4920 million for the quarter. Interested persons may visit the the company's upcoming Q4 2025 earning results page for